发明授权
- 专利标题： 5-HT3 RECEPTOR ANTAGONISTS
- 专利标题（中）： 5-HT3受体拮抗剂
-
申请号： EP13742355.4申请日： 2013-07-16
-
公开(公告)号： EP2875011B1公开(公告)日： 2018-01-10
- 发明人: HITCHCOCK, Stephen , MONENSCHEIN, Holger , REICHARD, Holly , SUN, Huikai , KIKUCHI, Shota , MACKLIN, Todd , HOPKINS, Maria
- 申请人： Takeda Pharmaceutical Company Limited
- 申请人地址： 1-1, Doshomachi-4-chome, Chuo-ku, Osaka-shi, Osaka 541-0045 JP
- 专利权人： Takeda Pharmaceutical Company Limited
- 当前专利权人： Takeda Pharmaceutical Company Limited
- 当前专利权人地址： 1-1, Doshomachi-4-chome, Chuo-ku, Osaka-shi, Osaka 541-0045 JP
- 代理机构： D Young & Co LLP
- 优先权： US201261672709P 20120717; US201261708521P 20121001
- 国际公布： WO2014014951 20140123
- 主分类号： C07D221/22
- IPC分类号： C07D221/22 ; C07D471/04 ; C07D453/02 ; C07D471/08 ; C07C53/18 ; A61K31/19 ; A61K31/5386 ; C07D451/12 ; C07D498/08 ; C07D519/00 ; C07C53/40
摘要：
which are useful for the treatment of diseases treatable by inhibition of 5-HT3 receptor such as emesis, pain, drug addiction, neurodegenerative and psychiatric disorders, and GI disorders. Also provided are pharmaceutical compositions containing such compounds and processes for preparing such compounds.
公开/授权文献
- EP2875011A1 5-HT3 RECEPTOR ANTAGONISTS 公开/授权日：2015-05-27
信息查询
